Evelo Biosciences Inc. (EVLO) Fundamentals

Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. Its lead product candidate under development is EDP1815, which is for the treatment of inflammatory diseases and the hyperinflammatory response associated with COVID-19. Other products in the pipeline include EDP1867 and EDP2939 for the treatment of inflammatory disease and EDP1908 for the treatment of cancer.
SHARE INFORMATION
Market Cap$ 285,103,379
Shares Outstanding107,993,704
Float76,612,178
Percent Float70.94%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.31
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions173
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months915,804
Institutional Holdings Percent70.2%
Institutional Sold Previous 3 Months3,213,916
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months27,975,871
Insider Holdings Percent0.7
Insider Sold Previous 3 Months14,778
Insider Shares Owned741,147
TRADING INFO
52 Week High$ 12.74
52 Week Low$ 1.42
52 Week High Change$ -72.90
21 Day Moving Average$ 2.4781
21 Day Extended Moving Average$ 2.5507
50 Day Moving Average$ 2.2846
50 Day Extended Moving Average$ 2.4268
200 Day Moving Average$ 4.3233
200 Day Extended Moving Average$ 4.1224
10 Day Average Volume107,412
20 Day Average Volume81,253
30 Day Average Volume101,908
50 Day Average Volume258,849
Alpha-0.018879
Beta1.5715
Standard Deviation0.300026
R20.078874
7 Day Price Change$ -0.07
7 Day Percent Change-2.58%
21 Day Price Change$ 0.46
21 Day Percent Change21.1%
30 Day Price Change$ 0.44
30 Day Percent Change20.0%
Month to Date Price Change$ 0.53
Month to Date Percent Change25.12%
Quarter to Date Price Change$ 0.53
Quarter to Date Percent Change25.12%
180 Day Price Change$ -1.36
180 Day Percent Change-34.0%
200 Day Price Change$ -1.91
200 Day Percent Change-41.98%
Year to Date Price Change$ -3.43
Year to Date Percent Change-56.51%

Evelo Biosciences Inc. (EVLO) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book8.30
Total Debt To Equity1.60
Int Coverage-29.00
Current Ratio4.50
Leverage Ratio6.20
Quick Ratio4.30
Long Term Debt To Capital0.57
VALUATION MEASURES
PE Ratio-1.30
Enterprise Value$ 260,320,686
Price to Sales0.00
Price to Free Cash-2.70
PE High Last 5 Years0.00
Price To Book8.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book8.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-95.58
Return on Equity-251.28
Return on Capital-114.46

Evelo Biosciences Inc. (EVLO) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOBalkrishan Gill
Emplyoees122
Last AuditUE
CIK0001694665
IndustryBiotechnology
SectorHealthcare
NAICSMedicinal and Botanical Manufacturing(325411)
CONTACT INFO
Address620 Memorial Drive
5th Floor
Cambridge, MA 2139
Websitehttps://www.evelobio.com
Facsimile-
Telephone+1 617 577-0300
Emailir@evelobio.com


Your Recent History
NASDAQ
EVLO
Evelo Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.